Mitogenic effect of arginine vasopressin on adult rat cardiac fibroblast: Involvement of PKC-erk1/2 pathway

Journal of Cardiovascular Pharmacology

Volumn 52, Issue 1, 2008, Pages 72-81

  Yan Ping, He ^a,b   Lian You, Zhao ^a   Qiang Sun, Zheng ^a   Shao Wei, Liu ^a   Xiao Yan, Zhao ^a   Xiao Long, Lu ^a   Xiao Lin, Niu ^a   Xia, Li ^b  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b INSTITUTE OF AVIATION MEDICINE   (China)

Author keywords

Arginine vasopressin; Cardiac hypertrophy; Extracellular signal regulated kinase 1 2; Protein kinase C

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ANTISENSE OLIGONUCLEOTIDE; ARGIPRESSIN; CALPHOSTIN C; CYCLIN A; CYCLIN D1; CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYCLIN E; ETHYLENE GLYCOL 1,2 BIS(2 AMINOPHENYL) ETHER N,N,N',N' TETRAACETIC ACID; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHORBOL MYRISTATE; PROTEIN KINASE C; VASOPRESSIN RECEPTOR;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; FIBROBLAST; HEART MUSCLE CELL; MITOGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; ANIMAL; CELL CULTURE; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; HEART MUSCLE; MALE; METABOLISM; MITOSIS; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; ARGININE VASOPRESSIN; CELL PROLIFERATION; CELLS, CULTURED; FIBROBLASTS; MALE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOSIS; MYOCARDIUM; PROTEIN KINASE C; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, VASOPRESSIN;

EID: 55949115678     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/FJC.0b013e31817f36b8     Document Type: Article

References (40)

1. Morgan HE, Baker KM. Cardiac hypertrophy. Mechanical, neural, and endocrine dependence. Circulation. 1991;83:13-25.
2. Naitoh M, Suzuki H, Murakami M, et al. Effects of oral AVP receptor antagonists OPC-21268 and OPC-31260 on congestive heart failure in conscious dogs. Am J Physiol. 1994;267:H2245-2254.
3. Uretsky BF, Verbalis JG, Generalovich T, et al. Plasma vasopressin response to osmotic and hemodynamic stimuli in heart failure. Am J Physiol. 1985;248:H396-402.
4. Kawano Y, Matsuoka H, Nishikimi T, et al. The role of vasopressin in essential hypertension. Plasma levels and effects of the V1 receptor antagonist OPC-21268 during different dietary sodium intakes. Am J Hypertens. 1997;10:1240-1244.
5. Chatterjee K. Neurohormonal activation in congestive heart failure and the role of vasopressin. Am J Cardiol. 2005;95:8B-13B.
6. Rouleau JL, Packer M, Moye L, et al. Prognostic value of neurohumoral activation in patients with an acute myocardial infarction: effect of captopril. J Am Coll Cardiol. 1994;24:583-591.
7. Cohn JN, Ferrari R, Sharpe N. Cardiac remodeling-concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling. J Am Coll Cardiol. 2000;35:569-582.
8. Weber KT, Brilla CG, Janicki JS. Myocardial fibrosis: functional significance and regulatory factors. Cardiovasc Res. 1993;27:341-348.
9. Yang F, Liu YH, Yang XP, et al. Myocardial infarction and cardiac remodeling in mice. Exp Physiol. 2002;87:547-555.
10. Nakamura Y, Haneda T, Osaki J, et al. Hypertrophic growth of cultured neonatal rat heart cells mediated by vasopressin V(1A) receptor. Eur J Pharmacol. 2000;391:39-48.
11. Fukuzawa J, Haneda T, Kikuchi K. Arginine vasopressin increases the rate of protein synthesis in isolated perfused adult rat heart via the V1 receptor. Mol Cell Biochem. 1999;195:93-98.
12. Tahara A, Tomura Y, Wada K, et al. Effect of YM087, a potent nonpeptide vasopressin antagonist, on vasopressin-induced protein synthesis in neonatal rat cardiomyocyte. Cardiovasc Res. 1998;38:198-205.
13. Brown RD, Ambler SK, Mitchell MD, et al. The cardiac fibroblast: therapeutic target in myocardial remodeling and failure. Annu Rev Pharmacol Toxicol. 2005;45:657-687.
14. Yang XD, Zhao LY, Zheng QS, et al. Effects of arginine vasopressin on growth of rat cardiac fibroblasts: role of V1 receptor. J Cardiovasc Pharmacol. 2003;42:132-135.
15. Lazou A, Bogoyevitch MA, Clerk A, et al. Regulation of mitogenactivated protein kinase cascade in adult rat heart preparations in vitro. Circ Res. 1994;75:932-941.
16. Boulton RA, Hodgson HJ. Assessing cell proliferation: a methodological review. Clin Sci (Lond). 1995;88:119-130.
17. Chiu T, Wu SS, Santiskulvong C, et al. Vasopressin-mediated mitogenic signaling in intestinal epithelial cells. Am J Physiol Cell Physiol. 2002; 282:C434-450.
18. Chen D, Fong HW, Davis JS. Induction of c-fos and c-jun messenger ribonucleic acid expression by prostaglandin F2{{alpha}} is mediated by a protein kinase C-dependent extracellular signal-regulated kinase mitogen-activated protein kinase pathway in bovine luteal cells. Endocrinology. 2001;142:887-895.
19. Liu P, Hopfner RL, Xu YJ, et al. Vasopressin-evoked [Ca2+]i responses in neonatal rat cardiomyocytes. J Cardiovasc Pharmacol. 1999;34:540-546.
20. Tahara A, Tsukada J, Tomura Y, et al. Effect of YM218, a nonpeptide vasopressin V(1A) receptor-selective antagonist, on rat mesangial cell hyperplasia and hypertrophy. Vascul Pharmacol. 2007;46:463-469.
21. Bhora FY, Kothary PC, Imanishi H, et al. Vasopressin stimulates DNA synthesis in cultured rat hepatocytes. J Surg Res. 1994;57:706-710.
22. Lagumdzija A, Pernow Y, Bucht E, et al. The effects of arg-vasopressin on osteoblast-like cells in endothelial nitric oxide synthase-knockout mice and their wild type counterparts. Peptides. 2005;26:1661-1666.
23. Zhao LY, Chen YQ, Tian JW, et al. [Effects of chelerythrine on cell proliferation and p27 expression of cardiac fibroblasts modulated by arginine vasopressin]. Zhonghua Yi Xue Za Zhi. 2003;83:421-424.
24. Murasawa S, Mori Y, Nozawa Y, et al. Angiotensin II type 1 receptorinduced extracellular signal-regulated protein kinase activation is mediated by Ca2+/calmodulin-dependent transactivation of epidermal growth factor receptor. Circ Res. 1998;82:1338-1348.
25. Olson ER, Shamhart PE, Naugle JE, et al. Angiotensin II-induced extracellular signal-regulated kinase 1/2 activation is mediated by protein kinase Cdelta and intracellular calcium in adult rat cardiac fibroblasts. Hypertension. 2008;51:704-711.
26. Sperti G, Colucci WS. Calcium influx modulates DNA synthesis and proliferation in A7r5 vascular smooth muscle cells. Eur J Pharmacol. 1991;206:279-284.
27. Xu YJ, Ouk Kim S, Liao DF, et al. Stimulation of 90- and 70-kDa ribosomal protein S6 kinases by arginine vasopressin and lysophosphatidic acid in rat cardiomyocytes. Biochem Pharmacol. 2000;59:1163-1171.
28. Aharonovitz O, Aboulafia-Etzion S, Leor J, et al. Stimulation of 42/44 kDa mitogen-activated protein kinases by arginine vasopressin in rat cardiomyocytes. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1998;1401:105-111.
29. Kim K, Nose K, Shibanuma M. Significance of nuclear relocalization of ERK1/2 in reactivation of c-fos transcription and DNA synthesis in senescent fibroblasts. J Biol Chem. 2000;275:20685-20692.
30. Nofer JR, Junker R, Pulawski E, et al. High density lipoproteins induce cell cycle entry in vascular smooth muscle cells via mitogen activated protein kinase-dependent pathway. Thromb Haemost. 2001;85:730-735.
31. Lavoie JN, L'Allemain G, Brunet A, et al. Cyclin D1 expression is regulated positively by the p42/p44MAPK and negatively by the p38/ HOGMAPK pathway. J Biol Chem. 1996;271:20608-20616.
32. Coats S, Flanagan WM, Nourse J, et al. Requirement of p27Kip1 for restriction point control of the fibroblast cell cycle. Science. 1996;272: 877-880.
33. Bhatt KV, Spofford LS, Aram G, et al. Adhesion control of cyclin D1 and p27Kip1 levels is deregulated in melanoma cells through BRAF-MEK-ERK signaling. Oncogene. 2005;24:3459-3471.
34. Foster JS, Fernando RI, Ishida N, et al. Estrogens down-regulate p27Kip1 in breast cancer cells through Skp2 and through nuclear export mediated by the ERK pathway. J Biol Chem. 2003;278:41355-41366.
35. Kortylewski M, Heinrich PC, Kauffmann ME, et al. Mitogen-activated protein kinases control p27/Kip1 expression and growth of human melanoma cells. Biochem J. 2001;357:297-303.
36. Girard F, Strausfeld U, Fernandez A, et al. Cyclin A is required for the onset of DNA replication in mammalian fibroblasts. Cell. 1991;67:1169-1179.
37. Alessi DR, Cuenda A, Cohen P, et al. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J Biol Chem. 1995;270:27489-27494.
38. Dudley DT, Pang L, Decker SJ, et al. A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc Natl Acad Sci U S A. 1995;92: 7686-7689.
39. Cavanaugh JE, Ham J, Hetman M, et al. Differential regulation of mitogen-activated protein kinases ERK1/2 and ERK5 by neurotrophins, neuronal activity, and cAMP in neurons. J Neurosci. 2001;21: 434-443.
40. Wang X, Studzinski GP. Phosphorylation of raf-1 by kinase suppressor of ras is inhibited by "MEK-specific" inhibitors PD 098059 and U0126 in differentiating HL60 cells. Exp Cell Res. 2001;268: 294-300.